Physician profile
Edward Taylor
NPI 1780614248
$465.85
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.84 · 2020: $43.92 · 2021: $86.57 · 2023: $150 · 2024: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $129.18 | 2024 | Spyglass Discover |
| Melinta Therapeutics, LLC | $124.99 | 2023 | Kimyrsa |
| Tei Biosciences INC | $28.42 | 2019 | |
| Merck Sharp & Dohme LLC | $28.41 | 2021 | |
| Kerecis Limited | $25.35 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $22.53 | 2021 | |
| Kci USA, INC. | $22.50 | 2020 | |
| Portola Pharmaceuticals, LLC | $22.16 | 2019 | |
| Nestle Healthcare Nutrition INC. | $22.08 | 2021 | |
| Z-Medica, LLC | $21.42 | 2020 | |
| Cook Medical LLC | $13.55 | 2021 | |
| Bolder Surgical LLC | $5.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.